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Abstract
Background: Hypoxic ischemic encephalopathy (HIE) occurs in one to three per 1000 live full-term births. Fifteen
to twenty percent will die in the postnatal period, and an additional 25 % will develop severe and permanent
neuropsychological sequalae. The control of growth and nutritional status in the fetus and neonate is a complex
mechanism, in which also hormones produced by adipose tissue, such as adiponectin and leptin are involved. The
aim of this study was to measure the levels of adiponectin, leptin and insulin in neonates with HIE at birth and in
early postnatal life and comparing them with normal healthy AGA and SGA neonates
Methods: This study carried out on 80 full-term neonates born in Minia university hospital during the period from
May 2013 to December 2014. They were divided into group I included 25 neonates with HIE and group II included
55 normal healthy neonates (30 appropriate for gestational age (AGA) and 25 small for gestational age (SGA)).
Weight, length, head circumference, body mass index (BMI), glucose, adiponectin, leptin and insulin levels were
measured for all neonates. Adiponectin, leptin and insulin levels were compared between neonates with HIE and
normal healthy neonates as well as between AGA and SGA neonates at birth, 2nd and 6th days of life.
Results: Adiponectin and leptin levels were significantly higher at birth then began to decrease during the first
postnatal week in all neonates while insulin level increased during the same period. Serum adiponectin levels were
significantly lower while serum leptin and insulin levels were significantly higher in neonates with HIE than healthy
neonates. In all neonates, the serum adiponectin level was positively correlated at birth with weight, length, BMI
and leptin levels but not with insulin level. In neonates with HIE, serum adiponectin level was not correlated with
weight, BMI, leptin level or insulin level. In all neonates, the serum leptin level was positively correlated at birth with
body weight, height and BMI. In neonates with HIE serum leptin levels were not correlated with weight, BMI or
insulin level after birth. There were no correlations between either leptin or adiponectin serum levels or any of the
studied parameters in neonates with HIE
Conclusions: Neonates who are suffering from HIE had lower serum levels of adiponectin and higher serum levels
of leptin and insulin than normal healthy neonates at birth and during the early postnatal period. The decline of
leptin and increased the insulin levels after birth in all neonates may be important for the stimulation of feeding
behavior and the acquisition of energy homeostasis during the early postnatal life. Positive significant correlations
between adiponectin, leptin, body weight and body mass indices were present in normal healthy neonates but not
in neonates with HIE reflecting the effect of hypoxia on the regulatory mechanisms controlling the adipose tissue
functions.
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Background
Hypoxic ischemic encephalopathy (HIE) occurs in one
to three per 1000 live full-term births [1]. About 15–
20 % will die in the postnatal period, and an additional
25 % will develop severe and permanent neuropsycho-
logical sequalae [2]. According to the latest estimates by
world health organization (WHO), 98 % of neonatal
deaths take place in the developing countries. Perinatal
asphyxia and birth injuries together contribute to al-
most 29 % of these deaths [3]. Hormones produced
by adipose tissue, such as adiponectin and leptin play
a critical role in the control of energy balance in both
of childhood and adult life [4]. Recent data show that
children may follow different growth patterns and
that those who display excessively rapid body mass
index (BMI) gains may be at higher risk for adult
obesity and adverse metabolic health [4, 5]. Adiponec-
tin, a protein hormone secreted by adipose tissue,
targets muscle and liver to increase uptake and catab-
olism of fatty acids and carbohydrates, promoting
insulin sensitivity [6]. Several studies reported a posi-
tive relationship between adiponectin and birth weight
[7, 8] but others did not [9–11].
Leptin, a hormone synthesized mainly by adipose tis-
sue acts on the hypothalamus to convey satiety and
regulate long-term energy balance [12]. There are many
studies about the leptin role in energy and nutrition
balance in human and mice [13–15]. It was hypothe-
sized that children have a relative leptin resistance
beneficial for their positive energy needs that occurs
after birth [16].
Although, there were many studies about the effect
of HIE on different tissue functions but its effect on
the adipose tissue functions is not clear until now
[17, 18].
The aim of this study was to measure the levels of adi-
ponectin, leptin and insulin in neonates with HIE at
birth and in early postnatal life and comparing them
with normal healthy AGA and SGA neonates.
Methods
Study subjects and samples collection
A total of 80 full-term neonates (37–42 weeks) born in
Minia university hospital during the period from May
2013 to December 2014 were enrolled in the study. They
were divided into two groups: Group I included 25 neo-
nates suffering from HIE and group II included 55 neo-
nates apparently normal healthy neonates not suffering
from any complications and matched with age and sex
as controls (30 AGA and 25 SGA neonates).
Inclusion criteria for neonates with HIE [19, 20]: as-
phyxia was defined as the presence of three or more of
the following: Profound metabolic acidosis (pH less than
7.00 and base deficit ≤ −12,mmol/L) on an umbilical
cord arterial blood sample, early onset of severe or mod-
erate neonatal encephalopathy in neonates born at 37 or
more weeks of gestation with neurological dysfunction
including altered level of consciousness and reactivity,
altered tone, hyperactive or absent reflexes, weak or ab-
sent Moro reflex and seizures, sentinel hypoxic event
during labor (heart rate of less than 100 beats per mi-
nute, late decelerations, or reduced beat-to-beat variabil-
ity or, severe electronic fetal monitoring abnormalities,
thick meconium stained amniotic fluid and respiratory
Fig. 1 Circulating levels of adiponectin, in SGA, AGA and neonates
with HIE at birth, 2nd, 6th days
Fig. 2 Circulating levels of leptin in SGA, AGA and neonates with
HIE at birth, 2nd, 6th days
Fig. 3 Circulating levels of Insulin in SGA, AGA and neonates with
HIE at birth, 2nd, 6th days
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depression, hypotonia, or bradycardia, a need for resus-
citation for more than 3 min with positive pressure ven-
tilation and oxygen immediately after birth, Apgar score
of 0 to 3 beyond 5 min, onset of multisystem involve-
ment within 72 h of birth and ∕or early imaging study
showing evidence of acute non focal cerebral abnormality.
SGA was defined as body weight below 2.5 Kg. and
gestational age at delivery was calculated according to last
menstrual period and confirmed by ultrasound examin-
ation during the first or early second trimester.
Informed consents were obtained from all parents of
neonates before inclusion in the study, for which local
departmental research committee approval was obtained.
All groups were subjected to anthropometric mea-
surements (weight, length and head circumference).
Body mass index (BMI) was calculated from the for-
mula: BMI = body weight (in Kg) / Length (in m2)
Blood samples [3 ml for each sample] were obtained
from all neonates within the first 24 h, 2nd and 6th days
of life. The obtained samples were centrifuged, and
serum was separated immediately by centrifugation and
stored at −20 °C until assays. Neonates with evidence of
malformations, genetic disorders, early onset sepsis,
twins and neonates of diabetic, hypertensive or pre-
eclamptic mothers were excluded from the study. Serum
glucose was determined using auto-analyzer BM/Hitachi.
Serum adiponectin concentration was assayed with an
adiponectin ELISA kit (Biovendor Laboratory Medicine,
Inc., Czech Republic). Serum Leptin was assayed with
Human Leptin ELISA kit (DRG international, Inc.,
Germany). Serum Insulin was assayed with human insu-
lin ELISA kit (BioSource Europe S.A., Belgium). For the
parameters measured, the intra-assay variation was 2.7–
8.6 %, 2.8–7.2 % and 2.5–6.9 % and inter-assay variation
of 12–28 %, 13.8–25.6 % and 11.6–15.5 % for adiponec-
tin, leptin and insulin respectively. Minimum detectable
concentrations (MDC) were as follows: adiponectin, 12.5
(μg/ml); leptin, 8.7 ng/ml and insulin, 22.4 (μIU/ml).
[21–23].
Statistical analysis
The results are presented as means ± SD. All calcula-
tions were made using the SPSS program (version 18).
Spearman correlation coefficient was used instead of
Pearson r correlation coefficient to compare individual
changes over time. We used ANOVA test for statistical
comparisons of baseline characteristics. Probability
values of less than 0.05 were considered significant.
Results
Serum adiponectin concentration was significantly lower
while the leptin and insulin concentrations were signifi-
cantly higher in neonates with HIE than normal healthy
neonates. As expected, all neonatal anthropometric mea-
surements were higher in the AGA than SGA group.
(Tables 1 & 2) and (Figures 1-3).
Insulin levels in neonates increased over the study
period; they were significantly lower at birth compared
to the time point’s 2nd and sixth days of life. SGA circu-
lating insulin level at birth was the lowest while HIE
circulating insulin level was the highest in comparison
to AGA circulating levels. At birth, 2nd and 6th days,
insulin concentrations were comparable between all
groups (Table 2).
Intra–group variance revealed that serum levels of adi-
ponectin, leptin and insulin were significantly changed
Table 1 Anthropometric and laboratory data of studied groups at birth
Item HIE SGA AGA p-value
(No.25) (No. = 25) (No. = 30)
Gest. Age(w) 38.7 ± 1.6 38.8 ± 1.6 39.16 ± 1.8 NS
M/F ratio 18(72 %)/7(28 %) 19(76 %)/6(24 %) 22(74 %)/8(26 %) NS
NVD/CS 11(44 %)/14(46 %) 13(52 %)/12(48 %) 16(54 %)/14(46 %) NS
Weight (Kg) 3.11 ± 0.32 1.91 ± 0.32 3.44 ± 0.24 0.001b
Length (cm) 44.50 ± 3.14 42.50 ± 3.14 46.75 ± 1.33 0.01a
BMI (kg/m2) 14.05 ± 0.61 9.55 ± 0.61 14.09 ± 0.89 0.001b
H.C (cm) 36.08 ± 1.88 31.08 ± 1.88 35.08 ± 1.13 0.01a
Apgar at 1 min 2.8 ± 0.3 4.8 ± 0.5 5.2 ± 0.1 NS
Apgar at 5 min 5.6 ± 0.6 8.3 ± 0.4 9.1 ± 0.6 NS
Adiponectine (μg/ml) 23.36 ± 5.86 28.2 ± 6.98 36.35 ± 10.55 0.001b
Leptin (ng/ml) 22.91 ± 3.73 4.48 ± 3.22 17.02 ± 3.01 0.001b
Insulin (μIU/ml) 67.13 ± 8.77 50.92 ± 9.10 55.0 ± 9.19 0.01a
Glucose (mmol/L) 4.64 ± 0.65 4.01 ± 0.86 4.21 ± 0.07 NS
Data is presented as n (%) for frequencies and mean ± S.D. for normal continuous variables. aSignificant, bhighly significant, NS not significant. HIE Hypoxic
Ischemic Encephalopathy, AGA Appropriate for gestational age, SGA small for gestational age, M/f male/female, NFD/CS normal vaginal delivery/cesarean section
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during the first week of life with adiponectin level was
the most affected one, while between group variance re-
vealed that neonates with HIE were the most affected
group followed by AGA group and lastly SGA as regards
these hormonal changes (Tables 3 & 4).
Linear regression analysis was performed using adipo-
nectin as a dependent variable and all parameters mea-
sured as independent variables and the body weight and
BMI followed by leptin levels were the most predictor
variables for adiponectin (R = −0.47; P = 0.03, R = −0.38;
P = 0.04 and R = −0.27; P = 0.1 4 respectively) (Not
shown in the results).
In all studied groups, the serum adiponectin level was
positively correlated at birth with body weight (r =
0.509, p < 0.001), length (r = 0.424, p < 0.01), BMI (r =
0.460, p < 0.001) and leptin levels (r = 0.355, p < 0.04)
but it was not correlated with the insulin level (r =
0.160, p = 0.277). In neonates with HIE, the serum
adiponectin level was not correlated with body weight
(r = −0.056, p = 0.816), BMI (r = −0.271, p = 0.247), lep-
tin level (r = 0.122, p = 0.609), or insulin level (r = 0.444,
p < 0.06).) (Table 5).
Serum leptin level was positively correlated at birth
with body weight (r = 0.935, p < 0.001), height (r = 0.818,
p < 0.001) and BMI (r = 0.918, p < 0.001) but it was not
correlated with the insulin level (r = 0.105, p = 0.479) in
all studied groups (Table 5).
Discussion
Analysis of adipose tissue histology of fat cells in new-
borns demonstrated two populations of cells in the
adipose tissue: small cells that do not contain fat and lar-
ger cells that contain fat but are small in their diameter
compared with adult fat cells [23]. Adiponectin seems to
be produced and secreted exclusively by adipocytes and
an increase in fat mass leads to down-regulation of adi-
ponectin in adults [24].
Sivan et al. 2003 [25] suggested that neonatal adipo-
nectin is derived mainly from fetal tissues and not from
maternal or placental tissues. Therefore, the possibility
that a facilitated transport of adiponectin from the ma-
ternal blood through the placenta is responsible for the
high levels of the hormone in cord blood seems unlikely.
In this study serum adiponectin concentration was sig-
nificantly lower in neonates with HIE than normal
healthy neonates reflecting the injurious effect of hyp-
oxia on the functions of the adipose tissues like other
tissues as myocardium, liver, renal and central nervous
system [17, 18]. Pardo et al. 2004 [26] speculated that
some endocrine, paracrine, and autocrine factor(s) that
are responsible for the known suppression of adiponec-
tin production could be reduced in newborns in com-
parison to older children. Kamoda et al. 2004 [27] found
that the levels of serum adiponectin were significantly
higher in all newborn neonates than in healthy children.
Table 2 Circulating levels of adiponectin, leptin, insulin and glucose in HIE and Non-HIE at birth, 2nd, 6th days
Item At birth Day 2 Day 6 p-value
Adiponectine (μg/ml) HIE 23.36 ± 5.86 23.27 ± 4.93 23.03 ± 5.7 P < 0.01a
Non HIE 32.64 ± 9.91 29.22 ± 6.78 26.4 ± 4.98
Leptin (ng/ml) HIE 22.91 ± 3.73 22.72 ± 4.73 22.47 ± 3.13 P < 0.001b
Non HIE 11.32 ± 7.01 9.98 ± 8.11 9.13 ± 7.22
Insulin (μIU/ml) HIE 67.13 ± 8.77 67.33 ± 8.77 67.49 ± 8.77 P < 0.01a
Non HIE 53.14 ± 9.30 54.06 ± 4.02 56.18 ± 4.33
aSignificant, bhighly significant, NS not significant. HIE Hypoxic Ischemic Encephalopathy, Non-HIE Non-Hypoxic Ischemic Encephalopathy
Table 3 Circulating levels of adiponectin, leptin, insulin and glucose in HIE and AGA at birth, 2nd and 6th days
Item Birth 2nd day 6th day
HIE AGA HIE AGA HIE AGA
Adiponectine (μg/ml) 23.36 ± 5.86 36.35 ± 10.55 23.27 ± 4.93 31.33 ± 9.98 23.03 ± 5.77 28.56 ± 9.38
P < 0.00b P < 0.00b P < 0.03a
Leptin (ng/ml) 22.91 ± 3.73 17.02 ± 3.01 22.72 ± 4.73 15.98 ± 3.01 22.47 ± 3.13 14.91 ± 2.90
P < 0.00b P < 0.00b P < 0.00b
Insulin (μIU/ml) 67.13 ± 8.77 55.0 ± 9.19 67.33 ± 8.77 56.98 ± 3.01 67.49 ± 8.77 60.4 ± 11.0
P < 0.00b P < 0.00b P < 0.00b
Glucose (mmol/L) 4.64 ± 0.65 4.21 ± 0.07 4.33 ± 0.06 4.53 ± 0.38 4.61 ± 0.11 4.36 ± 0.45
NS NS NS
aSignificant, bhighly significant, NS not significant. HIE Hypoxic Ischemic Encephalopathy, AGA Appropriate for gestational age
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In this study, the serum adiponectin level was posi-
tively correlated at birth with body weight, length and
BMI but not with insulin levels and these results are in
agreement with many others [28, 29]. This may be due
to a lack of negative feedback on adiponectin production
resulting from a lack of adipocyte hypertrophy and a low
percentage of body fat [30].
In this study, the mean value of serum adiponectin
was significantly lower in SGA than in AGA neonates
and this may be due to presence of a lower amount of a
brown adipose tissue in SGA neonates [27].
In neonates with HIE, the serum adiponectin level was
not correlated with body weight, BMI, leptin or insulin
levels and this may be attributed to the disturbed mech-
anisms controlling the growth factors release either from
the adipose tissues or from other organs [17, 18].
Leptin is synthesized and secreted in the placenta by
the mother and by the fetus [22]. It is detectable from
the second trimester and its level increases from the
middle of the third trimester towards term, according to
the stores of fetal adipose tissue [31, 32].
In this study, leptin and insulin concentrations were
significantly higher in neonates with HIE than normal
healthy neonates denoting the leptin and insulin insensi-
tivity in these neonates which may be due to the effect
of hypoxia and/or ischemia on the peripheral tissues re-
sistance. These results are in consistence with Tzschoppe
et al. 2011 [31].
Leptin acts as an endogenous mediator of neuropro-
tection during cerebral ischemia and exogenous leptin
administration protects against ischemic neuronal injury
in vitro and in vivo [33, 34]. Leptin and IL-1beta treat-
ment improves neuronal density and decreases apoptosis
in the newborn rat and experimental animals with
hypoxic-ischemic brain injury [35, 36].
The serum leptin level was positively correlated at
birth with body weight, height and BMI but not with in-
sulin level in all studied groups and these results are in
accordance with many other studies [37, 38]. In this
study we found leptin levels to be higher in AGA neo-
nates with respect to SGA neonates at birth and this is
in accordance with others [28, 29]. The previous results
were anticipated since leptin is mainly synthesized by
the white adipose tissue and released in the circula-
tion proportionally to the amount of body fat mass
[39, 40].
Ng et al. 2000 [41] suggested that the low leptin levels
in extremely preterm neonates may be a physiologic ad-
vantage as body energy utilization can be minimized and
nutritional reserves conserved for subsequent growth
and development.
Our results revealed that in neonates with HIE, the
serum leptin levels were not correlated with body
weight, BMI or insulin level after birth denoting the
disturbed mechanisms essential for metabolic control.
In this study, serum insulin level was higher in neo-
nates with HIE than normal healthy neonates and it was
not correlated with serum adiponectin level and these
results are in agreement with others [42, 43].
Iniguez et al. 2004 [43] found no correlations between
adiponectin and insulin levels at two years of life, How-
ever, Mami et al. 2008 [42] reported negative correlation
between adiponectin and insulin at birth and Yamamoto
et al. 2002 [44] reported negative correlations between
adiponectin and insulin in adults and that serum adipo-
nectin concentration predicts subsequent changes in in-
sulin resistance. This difference with our results may be
due to the small sample size, age group of studied pa-
tients or the methodology of the study.
In this study, there was no significant difference be-
tween SGA and AGA neonates regarding serum insulin
levels at birth. This is in agreement with Martinez-
Cordero et al. 2006 [28] and with other studies reported
that the cord blood c-peptide levels, a proxy for fetal
pancreatic insulin secretion, were correlated positively
with the birth weight [45, 46], but not with Yajnik et al.
Table 4 Linear regression analysis of the studied hormones in different studied groups during the first week of life
Item Confidence interval for B Standardized Coefficients P value
Lower Bound upper Bound B
Non HIE AGA neonate Adiponectin 0.1 0.015 0.274 0.009b
Leptin 0.33 0.045 2.6 0.011a
Insulin 0.002 0.09 0.214 0.04a
Non HIE SGA neonate Adiponectin 0.147 0.005 0.213 0.07
Leptin 0.27 0.06 0.15 0.21
Insulin 0.05 0.06 0.016 0.9
HIE neonates Adiponectin 0.2 0.022 0.374 0.001b
Leptin 0.13 0.025 1.6 0.01a
Insulin 0.02 0.09 0.224 0.03a
aSignificant, bhighly significant, NS not significant. HIE Hypoxic Ischemic Encephalopathy, AGA Appropriate for gestational age, SGA small for gestational age
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Table 5 Correlations between adiponectin and leptin levels and other studied parameters
Item HIE Non-HIE AGA Non-HIE SGA
Adiponectin Leptin Adiponectin Leptin Adiponectin Leptin
Gestational
age (weeks)
r = −0.15 r = 0.42 r = 0.70 r = 0.64 r = 0.40 r = 0.47
p = 0.71 p = 0.32 p < 0.001b p < 0.01a p < 0.01a p < 0.01a
Weight (Kg) r = −0.05 r = 0.36 r = 0.60 r = 0.93 r = 0.50 r = 0.73
p = 0.81 p = 0.11 p < 0.01a p < 0.001b p < 0.01a p < 0.01a
Length (cm) r = −0.23 r = 0.31 r = 0.52 r = 0.81 r = 0.42 r = 0.61
p = 0.96 p = 0.18 p < 0.01a p < 0.01a p < 0.01b p < 0.01a
BMI (kg/m2) r = −0.27 r = 0.22 r = 0.66 r = 0.91 r = 0.46 r = 0.71
p = 0.24 p = 0.350 p < 0.01a p < 0.001b p < 0.001b p < 0.01a
Insulin (μIU/
ml)
r = 0.44 r = 0.31 r = 0.26 r = 0.30 r = 0.16 r = 0.10
p = 0.06 p = 0.17 p = 0.27 p = 0.47 p = 0.27 p = 0.47
Adiponectine
(μg/ml)
—————————————— r = 0.12 ———————————— r = 0.55 ———————————— r = 045
p = 0.60 p < 0.0a p < 0.02a
Leptin (ng/ml) r = 0.12 ———————— r = 0.55 ———————————— r = 0.35 ————————————
p = 0.60 p < 0.04a p < 0.04a

















2002 [47] who reported that in Indian neonates, despite
their lower birth weight, have hyperinsulinemia.
In this study intra–group variance revealed that serum
levels of adiponectin, leptin and insulin were signifi-
cantly changed during the first week of life with adipo-
nectin level was the most affected one, while between
group variance revealed that neonates with HIE were the
most affected group followed by AGA group and lastly
SGA as regards these hormonal changes.
As expected, in this study all neonatal anthropometric
measurements were higher in neonates of AGA than
SGA group.
Measurement of the maternal levels of these hormones
and correlations between them and neonatal serum
levels as well as follow-up of these levels for longer pe-
riods (for example for 1 or 2 years) were limitation for
this work which need more financial support and large
number of patients.
These findings have further clinical implications for
pediatricians to understand the effect of hypoxia and or
ischemia on different organs of the body including adi-
pose tissue and the different mechanisms controlling its
functions.
Conclusions
Neonates with HIE had lower serum levels of adiponec-
tin and higher serum levels of leptin and insulin than
normal healthy neonates at birth and during the early
post natal period. SGA neonates had lower serum levels
of adiponectin and leptin but not insulin levels than
AGA neonates. Positive significant correlations between
adiponectin, leptin, body weight and body mass indices
were present in normal healthy neonates but not in neo-
nates with HIE reflecting the effect of hypoxia on the
regulatory mechanisms controlling the adipose tissue
functions.
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